Systematic review / meta-analysis / 2020
Vitamin D therapy improved lung function, walking distance, symptoms, and exacerbations in patients with COPD.
A meta-analysis of 25 articles with 2,670 participants evaluated the efficacy of vitamin D therapy in patients with COPD. Vitamin D therapy significantly improved FEV1 (SMD: 1.21, 95% CI: 0.76-1.66, P<0.01), FEV1/FVC (SMD: 1.07, 95% CI: 0.56-1.58, P<0.01), and 6-minute walk distance (MD: 8.82, 95% CI: 1.67-15.98, P=0.02). It also significantly reduced exacerbations (SMD: 0.39, 95% CI: 0.23-0.64, P<0.01), sputum volume (SMD: -6.02, 95% CI: -8.25 to 3.79, P<0.01), and COPD assessment test score (SMD: -1.19, 95% CI: -1.74 to 0.63, P<0.01).
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 2,670 participants with chronic obstructive pulmonary disease (COPD) across 25 articles
- What was measured
- FEV1, FEV1/FVC, exacerbations, sputum volume, 6-minute walk distance (6MWD), and CAT score
THE PAPER
The efficacy of vitamin D therapy for patients with COPD: a meta-analysis of randomized controlled trials.
Li X, He J, Yu M, Sun J. Ann Palliat Med, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.